Clearmind Medicine earnings were -$4.8M for the trailing 12 months ending Apr 30, 2025, with N/A growth year over year. The latest CMND earnings report on Apr 30, 2025 announced Q2 2025 earnings of -$783.9k, down 26.8% from last quarter. For the last reported fiscal year 2024 ending Oct 31, 2024, CMND reported annual earnings of -$5.3M, with -39% growth.
What were Clearmind Medicine's earnings last quarter?
Clearmind Medicine (NASDAQ: CMND) reported Q1 2025 earnings per share (EPS) of -$0.16, up 42.86% year over year. Total CMND earnings for the quarter were -$783.93 thousand. In the same quarter last year, Clearmind Medicine's earnings per share (EPS) was -$0.28.
As of the last Clearmind Medicine earnings report, Clearmind Medicine is currently losing money. Clearmind Medicine's net profit (also called net income) for the twelve months ending Apr 30, 2025 was -$4.83 million, a 30.15% decrease year over year.
What was CMND's earnings growth in the past year?
As of Clearmind Medicine's earnings date in Q2 2025, Clearmind Medicine's earnings has grown year over year. CMND earnings in the past year totalled -$4.83 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.